Perrigo Quick Ratio 2010-2024 | PRGO
Historical quick ratio values for Perrigo (PRGO) over the last 10 years.
| Perrigo Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2024-03-31 | $1.69B | $1.56B | 1.08 |
| 2023-12-31 | $1.69B | $1.59B | 1.07 |
| 2023-09-30 | $1.62B | $1.01B | 1.60 |
| 2023-06-30 | $1.61B | $1.06B | 1.52 |
| 2023-03-31 | $1.56B | $1.09B | 1.43 |
| 2022-12-31 | $1.57B | $1.11B | 1.41 |
| 2022-09-30 | $1.50B | $1.02B | 1.48 |
| 2022-06-30 | $1.57B | $1.02B | 1.55 |
| 2022-03-31 | $2.91B | $0.98B | 2.97 |
| 2021-12-31 | $2.84B | $1.59B | 1.79 |
| 2021-09-30 | $3.13B | $2.00B | 1.56 |
| 2021-06-30 | $3.30B | $1.99B | 1.67 |
| 2021-03-31 | $3.35B | $1.45B | 2.32 |
| 2020-12-31 | $2.07B | $1.38B | 1.50 |
| 2020-09-30 | $2.30B | $1.34B | 1.72 |
| 2020-06-30 | $2.77B | $1.86B | 1.49 |
| 2020-03-31 | $2.12B | $1.64B | 1.29 |
| 2019-12-31 | $1.76B | $1.34B | 1.32 |
| 2019-09-30 | $1.75B | $1.33B | 1.32 |
| 2019-06-30 | $2.50B | $1.79B | 1.39 |
| 2019-03-31 | $2.10B | $1.83B | 1.14 |
| 2018-12-31 | $2.02B | $1.54B | 1.32 |
| 2018-09-30 | $1.88B | $1.49B | 1.26 |
| 2018-06-30 | $1.90B | $1.54B | 1.23 |
| 2018-03-31 | $2.06B | $1.39B | 1.48 |
| 2017-12-31 | $2.01B | $1.44B | 1.40 |
| 2017-09-30 | $2.15B | $1.73B | 1.24 |
| 2017-06-30 | $2.00B | $1.63B | 1.23 |
| 2017-03-31 | $4.31B | $2.49B | 1.74 |
| 2016-12-31 | $2.01B | $1.84B | 1.10 |
| 2016-09-30 | $1.74B | $1.51B | 1.15 |
| 2016-06-30 | $2.13B | $2.06B | 1.04 |
| 2016-03-31 | $2.11B | $2.22B | 0.95 |
| 2015-12-31 | $1.89B | $2.55B | 0.74 |
| 2015-09-30 | $1.99B | $1.66B | 1.20 |
| 2015-06-30 | $2.34B | $1.69B | 1.38 |
| 2015-03-31 | $4.49B | $1.28B | 3.50 |
| 2014-12-31 | $4.72B | $1.33B | 3.56 |
| 2014-09-30 | $1.98B | $1.02B | 1.94 |
| 2014-06-30 | $1.92B | $1.08B | 1.79 |
| 2014-03-31 | $1.61B | $0.95B | 1.69 |
| 2013-12-31 | $1.58B | $0.96B | 1.65 |
| 2013-09-30 | $1.65B | $0.74B | 2.21 |
| 2013-06-30 | $1.53B | $0.75B | 2.05 |
| 2013-03-31 | $1.01B | $0.67B | 1.50 |
| 2012-12-31 | $1.14B | $0.64B | 1.79 |
| 2012-09-30 | $1.30B | $0.63B | 2.07 |
| 2012-06-30 | $1.25B | $0.65B | 1.91 |
| 2012-03-31 | $1.20B | $0.63B | 1.91 |
| 2011-12-31 | $1.15B | $0.67B | 1.73 |
| 2011-09-30 | $0.74B | $0.62B | 1.18 |
| 2011-06-30 | $0.87B | $0.61B | 1.44 |
| 2011-03-31 | $0.77B | $0.57B | 1.35 |
| 2010-12-31 | $0.68B | $0.59B | 1.16 |
| 2010-09-30 | $0.56B | $0.57B | 0.97 |
| 2010-06-30 | $0.95B | $0.92B | 1.03 |
| 2010-03-31 | $0.73B | $0.45B | 1.60 |
| 2009-12-31 | $0.75B | $0.49B | 1.54 |
| 2009-09-30 | $0.71B | $0.46B | 1.55 |
| 2009-06-30 | $0.77B | $0.50B | 1.54 |
| 2009-03-31 | $0.65B | $0.44B | 1.49 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.561B | $4.656B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.183B | 23.99 |
| Stryker (SYK) | United States | $129.169B | 30.94 |
| Boston Scientific (BSX) | United States | $112.541B | 35.85 |
| Medtronic (MDT) | Ireland | $103.915B | 15.56 |
| EssilorLuxottica (ESLOY) | France | $102.324B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.451B | 0.00 |
| Haleon (HLN) | United Kingdom | $39.452B | 28.80 |
| ResMed (RMD) | United States | $26.766B | 25.13 |
| Terumo (TRUMY) | Japan | $24.090B | 34.02 |
| Koninklijke Philips (PHG) | Netherlands | $23.739B | 18.84 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.313B | 14.25 |
| Baxter (BAX) | United States | $17.423B | 12.39 |
| Insulet (PODD) | United States | $14.284B | 63.33 |
| Demant (WILYY) | Denmark | $10.984B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.977B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.098B | 26.48 |
| BellRing Brands (BRBR) | United States | $7.479B | 35.18 |
| Lantheus Holdings (LNTH) | United States | $5.472B | 13.64 |
| GN Store Nord (GNNDY) | Denmark | $4.529B | 25.43 |
| Haemonetics (HAE) | United States | $4.368B | 21.54 |
| Neogen (NEOG) | United States | $3.591B | 34.54 |
| Prestige Consumer Healthcare (PBH) | United States | $3.418B | 16.27 |
| Envista Holdings (NVST) | United States | $2.910B | 12.01 |
| TG Therapeutics (TGTX) | United States | $2.845B | 80.04 |
| ICU Medical (ICUI) | United States | $2.837B | 25.04 |
| Green Thumb Industries (GTBIF) | United States | $2.671B | 52.29 |
| Agios Pharmaceuticals (AGIO) | United States | $2.568B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.271B | 12.61 |
| LeMaitre Vascular (LMAT) | United States | $1.800B | 52.76 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.781B | 0.00 |
| Warby Parker (WRBY) | United States | $1.539B | 0.00 |
| InMode (INMD) | Israel | $1.514B | 8.05 |
| AdaptHealth (AHCO) | United States | $1.353B | 10.06 |
| Verano Holdings (VRNOF) | United States | $1.275B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 10.78 |
| AtriCure (ATRC) | United States | $1.048B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.015B | 32.30 |
| BioLife Solutions (BLFS) | United States | $0.991B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.820B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.705B | 15.01 |
| Evolus (EOLS) | United States | $0.658B | 0.00 |
| PetIQ (PETQ) | United States | $0.647B | 20.92 |
| Surmodics (SRDX) | United States | $0.598B | 37.46 |
| VAREX IMAGING (VREX) | United States | $0.589B | 13.86 |
| Valneva SE (VALN) | France | $0.544B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.525B | 0.00 |
| Quanterix (QTRX) | United States | $0.490B | 0.00 |
| Jin Medical (ZJYL) | China | $0.457B | 0.00 |
| Biote (BTMD) | United States | $0.456B | 10.50 |
| TerrAscend (TSNDF) | Canada | $0.434B | 0.00 |
| ZimVie (ZIMV) | United States | $0.404B | 34.40 |
| OraSure Technologies (OSUR) | United States | $0.317B | 10.19 |
| Cerus (CERS) | United States | $0.312B | 0.00 |
| MacroGenics (MGNX) | United States | $0.282B | 0.00 |
| Zynex (ZYXI) | United States | $0.278B | 38.00 |
| Aurora Cannabis (ACB) | Canada | $0.278B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.254B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.250B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.248B | 24.61 |
| Omeros (OMER) | United States | $0.237B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.235B | 14.79 |
| High Tide (HITI) | Canada | $0.183B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.158B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.152B | 73.00 |
| FitLife Brands (FTLF) | United States | $0.151B | 21.43 |
| Quipt Home Medical (QIPT) | United States | $0.132B | 0.00 |
| Veru (VERU) | United States | $0.125B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Brainsway (BWAY) | Israel | $0.107B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 9.74 |
| InterCure (INCR) | Israel | $0.094B | 15.92 |
| Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| MariMed (MRMD) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.80 |
| Bright Green (BGXX) | United States | $0.056B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.056B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.018B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |